Patent · US Expired

3-(substituted)-2-indolinones compounds and use thereof as inhibitors of protein kinase activity

US6133305A · kind A · utility

74Cited by
8References
27Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 25, 1998
Grant dateOct 17, 2000
Priority date
Expiry dateSep 25, 2018

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D209/34
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention relates to novel 3-(substituted)-2-indolinones compounds and physiologically acceptable salts and prodrugs thereof which modulate the activity of protein kinases and therefore are expected to be useful in the prevention and treatment of protein kinase related disorders such as cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.